Brian D. Richards

Psilocybin occasioned mystical-type experiences: immediate and persisting dose-related effects

Matthew W. Johnson, R. Griffiths, U. McCann, 2011, Psychopharmacology.

Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial

Matthew W. Johnson, Annie Umbricht, R. Griffiths, 2016, Journal of psychopharmacology.

Top Ten Tips Palliative Care Clinicians Should Know About Psychedelic-Assisted Therapy in the Context of Serious Illness.

Monnica T. Williams, S. Fischer, J. Tulsky, 2022, Journal of palliative medicine.

Psilocybin-occasioned mystical-type experience in combination with meditation and other spiritual practices produces enduring positive changes in psychological functioning and in trait measures of prosocial attitudes and behaviors

Matthew W. Johnson, Katherine A. MacLean, R. Griffiths, 2017, Journal of psychopharmacology.

Characterization of individuals seeking treatment for caffeine dependence.

R. Griffiths, L. M. Juliano, Daniel P Evatt, 2012, Psychology of addictive behaviors : journal of the Society of Psychologists in Addictive Behaviors.

Development and Evaluation of a Therapist Training Program for Psilocybin Therapy for Treatment-Resistant Depression in Clinical Research

Elizabeth M. Nielson, S. Tai, Brian D. Richards, 2021, Frontiers in Psychiatry.

Relative Abuse Liability of GHB in Humans: A Comparison of Psychomotor, Subjective, and Cognitive Effects of Supratherapeutic Doses of Triazolam, Pentobarbital, and GHB

R. Griffiths, M. Mintzer, Brian D. Richards, 2006, Neuropsychopharmacology.